Skip to content

InvestorsNASDAQ: ANIX

Stock SEC Filings

Back to anixa.com

Corporate deck Contact Investor FAQs

Loading…

NASDAQ: ANIXBack to anixa.com

Company

Overview
Leadership
Governance
Contact

Investors

Press Releases
Events & Webcasts
Stock Information
SEC Filings

Resources

Presentations
Email Alerts
Investor FAQs

Anixa Biosciences, Inc. uses its investor relations website as a recognized channel for disclosing material, non-public information and for complying with its disclosure obligations under Regulation FD. Investors should monitor this site, along with the company's press releases, SEC filings, and public conference calls and webcasts.

© 2026 Anixa Biosciences, Inc.Privacy Terms Accessibility

Site by Front Yard and Crescendo Communications

We use cookies to power embedded market data and to remember your alert preferences. You can decline non-essential cookies.

Press releases

Announcements from Anixa Biosciences, published the moment they cross the wire. Get them by email.

2018

Oct 11, 2018
7:00 AM EDT
Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board
It has added to its Scientific Advisory Board, Jose Conejo-Garcia , MD PhD; Marco Davila , MD PhD; Linda Kelley , PhD; and Daniel Abate-Daga , PhD; the lead scientists from Moffitt Cancer Center developing a novel ovarian cancer CAR-T treatment.
Oct 05, 2018
7:00 AM EDT
Anixa Biosciences to Present at Artificial Intelligence Conference
It will present data from its ongoing studies utilizing Cchek™, Anixa's artificial intelligence (AI) driven early cancer detection technology, at the 30 th Anniversary AACR Special Conference – Convergence: Artificial Intelligence, Big Data and Prediction in Cancer.

PreviousPage 13 of 13Next →

Forward-looking statements

This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Anixa Biosciences' clinical trials, product candidates, regulatory plans, and business strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied. The Company undertakes no obligation to update any forward-looking statements except as required by law.